162 related articles for article (PubMed ID: 4581078)
21. Immunologic changes in regional lymph nodes of melanoma patients.
Hammer C; Lewis MG; Rowden G; Phillips T
Chir Forum Exp Klin Forsch; 1978; (1978):235-8. PubMed ID: 313322
[TBL] [Abstract][Full Text] [Related]
22. Role of autologous lymphocyte cytotoxicity in colonic neoplasia.
Gallagher P; Vose BM; Moore M; Schofield PF
Gut; 1982 Jan; 23(1):31-5. PubMed ID: 6976915
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated and humoral immune reactions to human tumours.
Baldwin RW; Embleton MJ; Jones JS; Langman MJ
Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
[No Abstract] [Full Text] [Related]
24. Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.
Vose BM; Vánky F; Klein E
Int J Cancer; 1977 Dec; 20(6):895-902. PubMed ID: 591128
[TBL] [Abstract][Full Text] [Related]
25. Specific immune response in human skin carcinoma.
Nairn RC; Guli EP; Nind AP; Muller HK; Rolland JM; Minty CC
Br Med J; 1971 Dec; 4(5789):701-5. PubMed ID: 4943032
[TBL] [Abstract][Full Text] [Related]
26. Significance of tumour associated antigens on human colonic carcinomata.
Embleton MJ
Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte cytotoxic activity on embroyonic colon target cell in patients with carcinoma of the colon.
Onody K; Kovács A; Petrányi GY+PETRANYI GY
Neoplasma; 1974; 21(3):291-5. PubMed ID: 4608237
[No Abstract] [Full Text] [Related]
28. Anti-tumor immunoreactivity in patients with malignant melanoma.
Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH
Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232
[No Abstract] [Full Text] [Related]
29. Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade.
Flannery GR; Chalmers PJ; Rolland JM; Nairn RC
Br J Cancer; 1973 Oct; 28(4):293-8. PubMed ID: 4202457
[TBL] [Abstract][Full Text] [Related]
30. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1971 Sep; 8(2):185-91. PubMed ID: 4332366
[No Abstract] [Full Text] [Related]
31. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
Mukherji B; Nashed AL; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the spontaneous lymphocyte toxicity in colonic carcinoma].
Eder E; Mühe E; Kratzsch G; Warnatz H
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1215-7. PubMed ID: 306168
[No Abstract] [Full Text] [Related]
33. Human stomach carcinoma-specific T cells derived from the tumour-draining lymph nodes.
Stulle K; Vollmers HP; Marquardt P; Müller-Hermelink HK
Br J Cancer; 1994 Dec; 70(6):1053-9. PubMed ID: 7981054
[TBL] [Abstract][Full Text] [Related]
34. Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells.
Hutchinson GH; Heinemann D; Symes MO; Williamson RC
Br J Cancer; 1981 Sep; 44(3):396-402. PubMed ID: 7284236
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
O'Neill PA; Mackler BF; Romsdahl MM
J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
[TBL] [Abstract][Full Text] [Related]
36. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
37. [Immune status of patients with malignant melanoma during combined therapy including local ultra-high frequency hyperthermia].
Risina DIa; Zhakov IG; Fradkin SZ; Zhabrid EA
Vopr Onkol; 1989; 35(12):1437-40. PubMed ID: 2532801
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte migration in malignant disease.
Crowther D; Wagstaff J
Clin Exp Immunol; 1983 Mar; 51(3):413-20. PubMed ID: 6342879
[TBL] [Abstract][Full Text] [Related]
39. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients.
de Vries JE; Rümke P
Int J Cancer; 1976 Feb; 17(2):182-90. PubMed ID: 942943
[TBL] [Abstract][Full Text] [Related]
40. Cellular immune reaction to human malignant melanoma and breast carcinoma cells.
Canevari S; Fossati G; Della Porta G
J Natl Cancer Inst; 1976 Apr; 56(4):705-9. PubMed ID: 1255793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
